These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24855206)

  • 21. Generation of Non-Alloreactive Antiviral Central Memory CD8 Human Veto T Cells for Cell Therapy.
    Bachar-Lustig E; Lask A; Eidelstein Y; Or-Geva N; Gidron-Budovsky R; Nathansohn-Levy B; Eyrich M; Liu WH; Dang G; Miranda KC; Ramirez A; Kaur I; Rezvani K; Shpall E; Champlin RE; Nagler A; Shimoni A; Barnees-Kagan S; Reisner Y
    Transplant Cell Ther; 2024 Jan; 30(1):71.e1-71.e13. PubMed ID: 37890590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of HLA-A*2402-restricted cytomegalovirus-specific T-cells following stem cell transplantation.
    Gondo H; Himeji D; Kamezaki K; Numata A; Tanimoto T; Takase K; Aoki K; Henzan H; Nagafuji K; Miyamoto T; Ishikawa F; Shimoda K; Inaba S; Tsukamoto H; Horiuchi T; Nakashima H; Otsuka T; Kato K; Kuroiwa M; Higuchi M; Shibuya T; Kamimura T; Kuzushima K; Tsurumi T; Kanda Y; Harada M
    Int J Hematol; 2004 Dec; 80(5):441-8. PubMed ID: 15646657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.
    Ciáurriz M; Zabalza A; Beloki L; Mansilla C; Pérez-Valderrama E; Lachén M; Bandrés E; Olavarría E; Ramírez N
    Cell Mol Life Sci; 2015 Nov; 72(21):4049-62. PubMed ID: 26174234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation.
    Liu J; Zhang X; Zhong JF; Zhang C
    Immunotherapy; 2019 Jan; 11(1):37-44. PubMed ID: 30702011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.
    Mangare C; Tischer-Zimmermann S; Riese SB; Dragon AC; Prinz I; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Guiver M; Moss PA; Mackinnon S
    Lancet; 2003 Oct; 362(9393):1375-7. PubMed ID: 14585640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD38
    Khandelwal P; Chaturvedi V; Owsley E; Lane A; Heyenbruch D; Lutzko CM; Leemhuis T; Grimley MS; Nelson AS; Davies SM; Jordan MB; Marsh RA
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):1-6. PubMed ID: 31442594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8-depleted donor leukocyte transfusions for cytomegalovirus antigenemia in patient with acute lymphoblastic leukemia treated with allogeneic CD34(+) cell transplantation.
    Okumura H; Yoshida T; Takamatsu H; Mochizuki Y; Takeshima M; Ohtake S; Ikeno T; Nakamura S; Nakao S
    Am J Hematol; 2000 Dec; 65(4):278-80. PubMed ID: 11074552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
    Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human HLA-A*02:01/CHM1+ allo-restricted T cell receptor transgenic CD8+ T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo.
    Blaeschke F; Thiel U; Kirschner A; Thiede M; Rubio RA; Schirmer D; Kirchner T; Richter GHS; Mall S; Klar R; Riddell S; Busch DH; Krackhardt A; Grunewald TG; Burdach S
    Oncotarget; 2016 Jul; 7(28):43267-43280. PubMed ID: 27281613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
    Kaeuferle T; Krauss R; Blaeschke F; Willier S; Feuchtinger T
    J Hematol Oncol; 2019 Feb; 12(1):13. PubMed ID: 30728058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation.
    Feuchtinger T; Opherk K; Bethge WA; Topp MS; Schuster FR; Weissinger EM; Mohty M; Or R; Maschan M; Schumm M; Hamprecht K; Handgretinger R; Lang P; Einsele H
    Blood; 2010 Nov; 116(20):4360-7. PubMed ID: 20625005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy.
    Guan L; Sun Y; Si Y; Yan Q; Han Z; Liu Y; Han T
    Front Immunol; 2024; 15():1367609. PubMed ID: 39035005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.
    Sauter CT; Bailey CP; Panis MM; Biswas CS; Budak-Alpdogan T; Durham A; Flomenberg N; Alpdogan O
    Bone Marrow Transplant; 2013 Sep; 48(9):1237-42. PubMed ID: 23624821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.
    Einsele H; Roosnek E; Rufer N; Sinzger C; Riegler S; Löffler J; Grigoleit U; Moris A; Rammensee HG; Kanz L; Kleihauer A; Frank F; Jahn G; Hebart H
    Blood; 2002 Jun; 99(11):3916-22. PubMed ID: 12010789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.
    Moins-Teisserenc H; Busson M; Scieux C; Bajzik V; Cayuela JM; Clave E; de Latour RP; Agbalika F; Ribaud P; Robin M; Rocha V; Gluckman E; Charron D; Socié G; Toubert A
    J Infect Dis; 2008 Sep; 198(6):818-26. PubMed ID: 18666855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
    Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
    Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytomegalovirus infection is associated with thymic dysfunction and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation.
    Kielsen K; Møller DL; Pedersen AE; Nielsen CH; Ifversen M; Ryder LP; Müller K
    Clin Immunol; 2024 Aug; 265():110302. PubMed ID: 38942161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.